Perioperative chemotherapy in the treatment of osteosarcoma: a 26-year single institution review

BACKGROUND: Chemotherapy in the multimodality treatment of osteosarcoma has improved survival. Reported outcomes on adult patients are limited. Poor necrosis rates post neoadjuvant chemotherapy (NAC) is considered an adverse prognostic factor and attempts have been made to improve survival in this g...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Kane, G M, Cadoo, K A, Walsh, E M, Emerson, R, Dervan, P, O’Keane, C, Hurson, B, O’Toole, G, Dudeney, S, Kavanagh, E, Eustace, S, Carney, D N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501053/
https://www.ncbi.nlm.nih.gov/pubmed/26175892
http://dx.doi.org/10.1186/s13569-015-0032-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501053/
https://www.ncbi.nlm.nih.gov/pubmed/26175892
http://dx.doi.org/10.1186/s13569-015-0032-0

Ejemplares similares